Radiation following surgery for oral cancer: Impact on local control

Laryngoscope

Volumn 113, Issue 6, 2003, Pages 933-935

  Magge, Keshav T ^b   Myers, Eugene N ^b   Johnson, Jonas T ^a  

^a University of Pittsburgh School of Medicine   (United States)

^b NONE

Author keywords

Postoperative radiation therapy

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; FOLLOW UP; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MOUTH CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TONGUE CANCER; TUMOR LOCALIZATION;

CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PENNSYLVANIA; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0038322388     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200306000-00003     Document Type: Article

References (6)

1. Sadeghi A, McLaren J, Grist WL, Tran L, Kuisk H. Value of radiation therapy in addition to surgery for cancer of the head and neck. Otolaryngol Head Neck Surg 1986;94:601.
2. Gavilan J, Prim MP, DeDiego JI, Hardisson D, Pozuelo A. Postoperative radiotherapy in patients with positive nodes after functional neck dissection. Ann Otol Rhinol Laryngol 2000;109:844-848.
3. Sessions DG, Spector GJ, Lenox J, et al. Analysis of treatment results for floor-of-mouth cancer. Laryngoscope 2000;110:1764-1772.
4. Forastiere AA. Induction and adjuvant chemotherapy for head and neck cancer: future perspectives. Acta Otorhinolaryngol Belg 1999;53:277-280.
5. Kish JA, Benedetti JK, Balcerzak SP, et al. Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study. Cancer J Sci Am 1999;5:307-311.
6. Agarwala SS. Adjuvant chemotherapy in head and neck cancer. Hematol Oncol Clin North Am 1999;13:743-752.